Sanjeev Kumar Sethi
Chief Operating Officer bei VIATRIS INC.
Profil
Derzeit hat Sanjeev Kumar Sethi die Position des Chief Operating Officer von Viatris, Inc. inne. Zuvor hatte er die Position des Head-Global Generics bei Mylan, Inc. inne, war Principal bei Ranbaxy Laboratories Ltd. und Principal bei Sandoz GmbH. Herr Sethi erwarb einen Hochschulabschluss an der Panjab University Chandigarh.
Aktive Positionen von Sanjeev Kumar Sethi
Unternehmen | Position | Beginn |
---|---|---|
VIATRIS INC. | Chief Operating Officer | 16.11.2020 |
Famy Life Sciences Pvt Ltd.
Famy Life Sciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Viatris, Inc., Famy Life Sciences Pvt Ltd. is a pharmaceutical company based in Ahmedabad, India. Founded in 2008, Famy Life Sciences was acquired by Viatris, Inc. on January 03, 2023 for $3.41 million. | Director/Board Member | 09.01.2020 |
Ehemalige bekannte Positionen von Sanjeev Kumar Sethi
Unternehmen | Position | Ende |
---|---|---|
Mylan Pharmaceuticals Pvt Ltd.
Mylan Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Mylan Pharmaceuticals Pvt Ltd. is an Indian pharmaceutical company. The private company is based in Bangalore, India. Mylan Pharmaceuticals values its workforce of about 15,000 people and encourages them to connect, collaborate, and communicate. | Chief Operating Officer | 01.11.2020 |
Mylan Pharmaceuticals Pvt Ltd.
Mylan Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Mylan Pharmaceuticals Pvt Ltd. is an Indian pharmaceutical company. The private company is based in Bangalore, India. Mylan Pharmaceuticals values its workforce of about 15,000 people and encourages them to connect, collaborate, and communicate. | Chief Operating Officer | - |
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Corporate Officer/Principal | - |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Corporate Officer/Principal | - |
RANBAXY LABORATORIES LIMITED | Corporate Officer/Principal | - |
Ausbildung von Sanjeev Kumar Sethi
Panjab University Chandigarh | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
VIATRIS INC. | Health Technology |
Private Unternehmen | 6 |
---|---|
Mylan, Inc.
Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Health Technology |
Ranbaxy Laboratories Ltd.
Ranbaxy Laboratories Ltd. Pharmaceuticals: GenericHealth Technology Ranbaxy Laboratories Ltd. operated as an integrated international pharmaceutical organization. The company engaged in the marketing, production and distribution of pharmaceutical products. It manufactured and markets molecules and their combinations to therapies, which include anti-infective, cardiovascular, pain management, central nervous system, gastrointestinal, respiratory, dermatology, orthopedics, nutritionals and urology. The company was founded on June 16, 1961 and headquartered in Gurgaon, India. | Health Technology |
Mylan Laboratories Ltd.
Mylan Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Mylan Laboratories Ltd. manufactures and supplies active pharmaceutical ingredients. The firm operates through two segments: Pharmaceuticals and Medical Supplies. It manufactures and supplies generic and branded generic formulations to various markets, including North America, Europe and Asia Pacific. Mylan Laboratories was founded on November 29, 1984 and is headquartered in Hyderabad, India. | Health Technology |
Sandoz GmbH
Sandoz GmbH Pharmaceuticals: MajorHealth Technology Sandoz GmbH manufactures generic pharmaceuticals and biotechnological drugs. Its products includes bio-similars, inhalers, patches, injectables, and oral solids. The company was founded in 1946 and is headquartered in Kundl, Austria. | Health Technology |
Mylan Pharmaceuticals Pvt Ltd.
Mylan Pharmaceuticals Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of Viatris, Inc., Mylan Pharmaceuticals Pvt Ltd. is an Indian pharmaceutical company. The private company is based in Bangalore, India. Mylan Pharmaceuticals values its workforce of about 15,000 people and encourages them to connect, collaborate, and communicate. | Health Technology |
Famy Life Sciences Pvt Ltd.
Famy Life Sciences Pvt Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Viatris, Inc., Famy Life Sciences Pvt Ltd. is a pharmaceutical company based in Ahmedabad, India. Founded in 2008, Famy Life Sciences was acquired by Viatris, Inc. on January 03, 2023 for $3.41 million. | Commercial Services |